Comparing Dayvigo vs Mirtazapine
| Dayvigo | Mirtazapine |
|
|---|
| Dayvigo lemborexant | Mirtazapine |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescribed for Insomnia. Dayvigo may also be used for purposes not listed in this medication guide. |
Mirtazapine may be used in the treatment of depression; however, its use may be limited by its prominent sedative effects. Prescribed for Depression, Major Depressive Disorder. May also be prescribed... View more |
Choose a suggestion below Popular Comparisons
|
|||||||||||||||
| More about Dayvigo (lemborexant) | More about Mirtazapine | ||||||||||||||||
| Generic Status | |||||||||||||||||
|
No lower-cost generic available |
|||||||||||||||||
| Availability | |||||||||||||||||
|
Prescription only |
Prescription only |
||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Dayvigo has an average rating of 4.0 out of 10 from a total of 136 ratings on Drugs.com. 26% of reviewers reported a positive effect, while 60% reported a negative effect. |
Mirtazapine has an average rating of 6.8 out of 10 from a total of 1790 ratings on Drugs.com. 55% of reviewers reported a positive effect, while 22% reported a negative effect. |
||||||||||||||||
| Drug Class | |||||||||||||||||
| Side Effects | |||||||||||||||||
|
See the full Dayvigo side effects document. |
Commonly reported side effects include: severe sedation, constipation, drowsiness, increased serum cholesterol, weight gain, fatigue, insomnia, increased appetite, xerostomia, and decreased appetite. See the full mirtazapine side effects document. |
||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Dayvigo prices |
View all mirtazapine prices |
||||||||||||||||
| Dosage Form(s) Available | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
|
N/A |
Remeron, Remeron SolTab | ||||||||||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | |||||||||||||||||
|
19 hours |
40 hours |
||||||||||||||||
| CSA Schedule** View glossary of terms | |||||||||||||||||
|
Some potential for abuse
Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Summary unavailable. See the full Pregnancy Warnings document. |
Category C
Risk cannot be ruled out
See the full Pregnancy Warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 402 drugs are known to interact with Dayvigo:
|
A total of 615 drugs are known to interact with mirtazapine:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
|||||||||||||||||
| Disease Interactions | |||||||||||||||||
| First Approval Date | |||||||||||||||||
|
December 20, 2019 |
June 14, 1996 |
||||||||||||||||
| WADA Class View World Anti-Doping Agency classifications. | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| More Information | |||||||||||||||||
| Patient resources | |||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.